These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300 [TBL] [Abstract][Full Text] [Related]
45. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy. Klinkenberg-Knol EC; Meuwissen SG Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868 [TBL] [Abstract][Full Text] [Related]
46. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G; Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305 [TBL] [Abstract][Full Text] [Related]
47. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Collen MJ; Strong RM Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194 [TBL] [Abstract][Full Text] [Related]